TCMD vs. GMED

Last updated Jun 3, 2026

TCMD (Tactile Systems Technology, Inc.) and GMED (Globus Medical, Inc.) are both stocks. Both operate in the Medical Devices industry within the Healthcare sector. Over the past 5 years, TCMD returned -13.59%/yr vs 2.11%/yr for GMED. At a 0.37 correlation, their price movements are largely independent.

Performance

TCMD vs. GMED - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tactile Systems Technology, Inc. (TCMD) and Globus Medical, Inc. (GMED). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, TCMD achieves a -15.83% return, which is significantly lower than GMED's -10.38% return.

TCMD

• 1D: 1.79%
• 1M: 6.64%
• YTD: -15.83%
• 6M: -6.65%
• 1Y: 146.81%
• 3Y*: 1.69%
• 5Y*: -13.59%
• 10Y*: —

GMED

• 1D: -1.92%
• 1M: -14.33%
• YTD: -10.38%
• 6M: -12.11%
• 1Y: 32.72%
• 3Y*: 11.94%
• 5Y*: 2.11%
• 10Y*: 12.15%

*Multi-year figures are annualized to reflect compound growth (CAGR)

TCMD vs. GMED - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
TCMD Tactile Systems Technology, Inc.	-15.83%	69.29%	19.79%	24.56%	-39.67%	-57.65%	-33.43%	48.21%	57.18%	76.60%
GMED Globus Medical, Inc.	-10.38%	5.56%	55.21%	-28.25%	2.87%	10.70%	10.77%	36.04%	5.30%	65.66%

Correlation

The correlation between TCMD and GMED is 0.49, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.49
Correlation (3Y) Calculated over the trailing 3-year period	0.39
Correlation (5Y) Calculated over the trailing 5-year period	0.41
Correlation (All Time) Calculated using the full available price history since Jul 29, 2016	0.37

The correlation between TCMD and GMED shifts across timeframes, from 0.37 (all time) to 0.49 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap TCMD : $550.72M GMED : $10.81B
EPS TCMD : $0.89 GMED : $4.29
PE Ratio TCMD : 27.47 GMED : 18.25
PEG Ratio TCMD : 0.69 GMED : 0.19
PS Ratio TCMD : 1.62 GMED : 3.45
PB Ratio TCMD : 2.53 GMED : 2.29
Total Revenue (TTM) TCMD : $343.52M GMED : $3.10B
Gross Profit (TTM) TCMD : $254.06M GMED : $1.58B
EBITDA (TTM) TCMD : $38.53M GMED : $803.34M

Return for Risk

TCMD vs. GMED — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TCMD

TCMD Risk / Return Rank: 91
TCMD Sharpe Ratio Rank: 90
TCMD Sortino Ratio Rank: 94
TCMD Omega Ratio Rank: 93
TCMD Calmar Ratio Rank: 89
TCMD Martin Ratio Rank: 89

GMED

GMED Risk / Return Rank: 67
GMED Sharpe Ratio Rank: 63
GMED Sortino Ratio Rank: 70
GMED Omega Ratio Rank: 66
GMED Calmar Ratio Rank: 68
GMED Martin Ratio Rank: 71

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TCMD vs. GMED - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tactile Systems Technology, Inc. (TCMD) and Globus Medical, Inc. (GMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	TCMD	GMED	Difference
Sharpe ratio Return per unit of total volatility	2.25	0.69	+1.56
Sortino ratio Return per unit of downside risk	4.01	1.73	+2.27
Omega ratio Gain probability vs. loss probability	1.50	1.21	+0.29
Calmar ratio Return relative to maximum drawdown	4.58	1.47	+3.11
Martin ratio Return relative to average drawdown	11.69	4.15	+7.53
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

TCMD vs. GMED - Sharpe Ratio Comparison

The current TCMD Sharpe Ratio is 2.25, which is higher than the GMED Sharpe Ratio of 0.69. The chart below compares the historical Sharpe Ratios of TCMD and GMED, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	TCMD	GMED	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.25	0.69	+1.56
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.23	0.06	-0.28
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.34	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.15	0.39	-0.24

Drawdowns

TCMD vs. GMED - Drawdown Comparison

The maximum TCMD drawdown since its inception was -91.41%, which is greater than GMED's maximum drawdown of -47.91%. Use the drawdown chart below to compare losses from any high point for TCMD and GMED.

Drawdown Indicators

	TCMD	GMED	Difference
Max Drawdown Largest peak-to-trough decline	-91.41%	-47.91%	-43.50%
Max Drawdown (1Y) Largest decline over 1 year	-32.13%	-21.95%	-10.18%
Max Drawdown (3Y) Largest decline over 3 years	-63.25%	-44.40%	-18.85%
Max Drawdown (5Y) Largest decline over 5 years	-88.51%	-47.91%	-40.60%
Max Drawdown (10Y) Largest decline over 10 years	—	-47.91%	—
Current Drawdown Current decline from peak	-68.00%	-19.18%	-48.82%
Average Drawdown Average peak-to-trough decline	-49.34%	-15.32%	-34.02%
Ulcer Index Depth and duration of drawdowns from previous peaks	12.58%	7.76%	+4.82%

Volatility

TCMD vs. GMED - Volatility Comparison

Tactile Systems Technology, Inc. (TCMD) has a higher volatility of 15.06% compared to Globus Medical, Inc. (GMED) at 12.75%. This indicates that TCMD's price experiences larger fluctuations and is considered to be riskier than GMED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TCMD	GMED	Difference
Volatility (1M) Calculated over the trailing 1-month period	15.06%	12.75%	+2.31%
Volatility (6M) Calculated over the trailing 6-month period	35.80%	22.22%	+13.58%
Volatility (1Y) Calculated over the trailing 1-year period	65.76%	47.86%	+17.90%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	60.49%	37.86%	+22.63%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	56.63%	35.47%	+21.16%

Dividends

TCMD vs. GMED - Dividend Comparison

Neither TCMD nor GMED has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

TCMD vs. GMED - Profitability Comparison

The chart below illustrates the profitability comparison between Tactile Systems Technology, Inc. and Globus Medical, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

TCMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Tactile Systems Technology, Inc. reported a gross profit of 51.71M and revenue of 75.27M. Therefore, the gross margin over that period was 68.7%.

GMED - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Globus Medical, Inc. reported a gross profit of 0.00 and revenue of 759.85M. Therefore, the gross margin over that period was 0.0%.

TCMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Tactile Systems Technology, Inc. reported an operating income of -1.53M and revenue of 75.27M, resulting in an operating margin of -2.0%.

GMED - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Globus Medical, Inc. reported an operating income of 150.39M and revenue of 759.85M, resulting in an operating margin of 19.8%.

TCMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Tactile Systems Technology, Inc. reported a net income of -1.76M and revenue of 75.27M, resulting in a net margin of -2.3%.

GMED - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Globus Medical, Inc. reported a net income of 124.30M and revenue of 759.85M, resulting in a net margin of 16.4%.

Frequently Asked Questions

Can I hold both TCMD and GMED in my portfolio?

TCMD and GMED have a correlation of 0.49, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, TCMD or GMED?

TCMD has higher volatility (15.06%) compared to GMED (12.75%). In terms of maximum drawdown, TCMD dropped -91.41% vs GMED's -47.91%.

Which has better risk-adjusted returns?

TCMD currently has the higher Sharpe Ratio (2.25 vs 0.69), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.